Genentech, a member of the Roche Group (RHHBY.PK), announced positive results from the pivotal Phase III GALLIUM study in people with previously untreated follicular lymphoma, the most common type of indolent (slow-growing) non-Hodgkin's lymphoma or ... RTTNews.com, 1 month ago
2 images for "genentech rank"
On May 12, Zacks Investment Research upgraded Kite Pharma, Inc . KITE to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell) Why the Upgrade? Kite reported results for the first quarter 2016 on May 9. Kite's track record has been satisfactory so ...Yahoo! Finance UK and Ireland, 1 month ago
Epizyme, Inc. EPZM announced that it has entered into a collaboration agreement with Roche Holding AG's RHHBY Genentech to evaluate its first-in-class EZH2 inhibitor, tazemetostat, in combination Genentech's Tecentriq (atezolizumab). The ...Zacks.com, 1 week ago
(GLOBE NEWSWIRE) -- Digital health technology leader WellDoc ® has expanded its leadership team with two new C-level executives and a key executive director. Healthcare finance veteran Jeff Lehrfeld has joined the company from Magellan Health as ...Citybizlist, 1 day ago WellDoc®, a Digital Health Technology Leader, Expands Leadership Team with Roster of Seasoned Healthcare Executives 4 Traders, 2 days ago
0 Flares 0 Flares × ASCO 2016 just wrapped up. It's the Super Bowl of medical conferences and sets all the trends—including the social ones. The last two years at ASCO were about volume and pharma. Twitter impressions around ASCO grew by ...PM 360, 1 day ago
Glassdoor is touted as the most transparent jobs and recruiting marketplace globally. The reviews, the posts on Glassdoor are usually done by employees (anonymously) which give a clear perspective on how the companies, CEOs, top leaders perform. ...People Matters, 1 week ago
Background - from hero to goat They loved it at $400 going to $500 on its way to $600, then they started disliking it at $500 on its way to $400. Now that it's $354, are the traders recoiling in horror as they push Regeneron (NASDAQ: REGN ) to ...Seeking Alpha, 1 week ago
(1)Which products are to become the next batch of drugs for critical illnesses with price largely re
National Health and Family Planning Commission of the P.R.C. announced the results of the price negotiation for the first batch of pharmaceutical products on May 20, involving three pharmaceutical products--tenofovir disoproxil fumarate (TDF) (GSK ...CPhI.cn, 1 week ago
ROCHE : employees raise funds for vulnerable children in over 90 communities around the world; A record number of countries and sites participate in the 13th Roche Children's Walk
Basel -- Today, Roche (SIX: RO, ROG; OTCQX: RHHBY) employees in 70 countries and 141 sites come together to participate in the 2016 Roche Children's Walk, which takes place on the International Day of the African Child. All of the funds raised ...4 Traders, 2 weeks ago Roche employees raise funds for vulnerable children in over 90 communities around the world World Pharma News, 1 week ago
Few areas of business attract as much attention as new ventures, and few aspects of new-venture creation attract as much attention as the business plan. Countless books and articles in the popular press dissect the topic. A growing number of annual ...Harvard Business Review, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!